as of 12-31-2025 3:54pm EST
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | WIXOM |
| Market Cap: | 35.1M | IPO Year: | 1998 |
| Target Price: | $2.50 | AVG Volume (30 days): | 235.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $2.41 | Next Earning Date: | 11-12-2025 |
| Revenue: | $75,577,000 | Revenue Growth: | -23.60% |
| Revenue Growth (this year): | -32.2% | Revenue Growth (next year): | 8.12% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$0.87
Shares
5,079
Total Value
$4,418.73
Owned After
140,372
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| COOPER JOHN G | RMTI | Director | Nov 18, 2025 | Sell | $0.87 | 5,079 | $4,418.73 | 140,372 |
See how RMTI stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "RMTI Rockwell Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.